Alethia Young - 21 Feb 2023 Form 4 Insider Report for Graphite Bio, Inc. (LENZ)

Role
Chief Financial Officer
Signature
/s/ Zed Zduniak, attorney-in-fact
Issuer symbol
LENZ
Transactions as of
21 Feb 2023
Net transactions value
$0
Form type
4
Filing time
23 Feb 2023, 16:04:27 UTC
Previous filing
09 Jan 2023
Next filing
19 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRPH Stock Option (right to buy) Award $0 +220,000 $0.000000 220,000 21 Feb 2023 Common Stock 220,000 $2.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.